微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -49.68% | -61.09% | -12.02% | 143/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -44.35% | -128.73% | -116.34% | 146/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -20.5% | -148.79% | 60.21% | 144/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -51.52% | -48.22% | -67.06% | 143/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -30.84% | -47.42% | -59.05% | 146/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -19.39% | -55.74% | -135.32% | 146/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -8.24% | -16.55% | 76.29% | 140/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -34.76% | -30.87% | -66.16% | 140/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -20.92% | -21.84% | -68.03% | 141/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -12.45% | -20.64% | -76.1% | 142/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -7.07% | -35.7% | 73.38% | 139/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -26.56% | 58.38% | -54.69% | 138/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -17.17% | 55.47% | -66.38% | 135/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -10.32% | 55.95% | -98.08% | 139/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -5.21% | 2% | 91.84% | 130/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -63.82% | -34.64% | -65.51% | 144/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | -38.56% | 2% | -64.58% | 130/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -23.43% | -4.88% | 50.57% | 138/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -47.4% | 2% | -112.18% | 138/158 | 3.66% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | -22.34% | 2% | 2% | 127/158 | 4.23% | 哈三联 | 27.17% | 行业排名> |